Financial statements Labderm Essence
Balance sheet data of LABDERM ESSENCE
|
Year
|
2021
|
2023
|
|---|---|---|
| Total assets | 366 222,23 | 784 199,70 |
| A. Fixed assets | 185 737,47 | 522 183,76 |
| B. Current assets | 180 484,76 | 262 015,94 |
| C. Share capital contributions (basic funds) | 0,00 | - |
| D. Own shares (stocks) | 0,00 | - |
| Total liabilities | 366 222,23 | 784 199,70 |
| A. Equity | -15 357,76 | 16 521,81 |
| B. Liabilities and provisions for liabilities | 381 579,99 | 767 677,89 |
| I. Long-term liabilities | - | - |
| II. Short-term liabilities | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.